EPI2ME Labs 23.01.01 Release![Stephen Rudd]()
Dear Nanopore Community, The EPI2ME Labs application has been updated to revision v4.1.1. This…
January 25, 2023
1 min
#releases 40
EPI2ME Labs 22.12.01 Release![Stephen Rudd]()
Dear Nanopore Community, We are delighted to release a new version of our EPI2ME Labs desktop…
December 07, 2022
1 min
EPI2ME Labs 22.11.01 Release![Stephen Rudd]()
Dear Nanopore Community, With this month’s update to our EPI2ME Labs product we are delighted to…
November 16, 2022
1 min
EPI2ME Labs 22.08.02 Release![Stephen Rudd]()
Dear Nanopore Community We have released a Kraken2 server software that has been implemented to…
September 21, 2022
2 min
EPI2ME Labs 22.08.01 Release![Stephen Rudd]()
Dear Nanopore Community We are delighted to introduce two new bioinformatics workflows and a…
August 24, 2022
2 min
EPI2ME Labs 22.07.02 Release![Stephen Rudd]()
Dear Nanopore Community, Our workflow for SARS-CoV-2 genome analysis, wf-artic , has been updated…
July 27, 2022
1 min
Related Links
© 2008 - 2026 Oxford Nanopore Technologies plc. All rights reserved. Registered Office: Gosling Building, Edmund Halley Road, Oxford Science Park, OX4 4DQ, UK | Registered No. 05386273 | VAT No 336942382. Oxford Nanopore Technologies, the Wheel icon, AmPORE-TB, EPI2ME, GridION, MinION, MinKNOW, PromethION, P2 Solo, and P2 are registered trademarks or the subject of trademark applications of Oxford Nanopore Technologies plc in various countries. Information contained herein may be protected by copyright, patents or patents pending of Oxford Nanopore Technologies plc. All other brands and names contained are the property of their respective owners. Oxford Nanopore Technologies products are RUO. Products labelled/branded as Oxford Nanopore Diagnostics may be RUO or may be regulated as in‐vitro diagnostic devices in some jurisdictions, please check individual product labelling.